Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Awakn Life Sciences Corp (AWKNF)

Awakn Life Sciences Corp (AWKNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Awakn Life Sciences Announces Completion of Arrangement and Sale to Solvonis Therapeutics plc Newsfile - Tue May 27, 2025

Toronto, Ontario--(Newsfile Corp. - May 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn" or the "Company"), is pleased to announce, further to its press releases...

AWKNF : 0.0650 (-18.44%)
AWKN.CN : 0.0950 (unch)
Awakn Life Sciences Announces Shareholder Approval of Arrangement Newsfile - Wed Apr 23, 2025

Toronto, Ontario--(Newsfile Corp. - April 23, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn" or the "Company"), is pleased to announce that further to its press releases...

AWKNF : 0.0650 (-18.44%)
AWKN.CN : 0.0950 (unch)
Awakn Life Sciences Provides Supplemental Disclosure in Connection with Proposed Plan of Arrangement Newsfile - Fri Apr 11, 2025

Toronto, Ontario--(Newsfile Corp. - April 11, 2025) - Further to its press release dated February 27, 2025 and its management information circular dated May 10, 2025 (the "Circular"), Awakn Life Sciences...

AWKNF : 0.0650 (-18.44%)
AWKN.CN : 0.0950 (unch)
Awakn Life Sciences Enters into Arrangement Agreement for The Acquisition of Awakn by Solvonis Therapeutics plc Newsfile - Thu Feb 27, 2025

Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing...

AWKNF : 0.0650 (-18.44%)
AWKN.CN : 0.0950 (unch)
Awakn Life Sciences Provides Update on R&D Programs, Progressing Novel Therapeutics for Alcohol Use Disorder and PTSD Newsfile - Mon Jan 27, 2025

Toronto, Ontario--(Newsfile Corp. - January 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company focused on...

AWKNF : 0.0650 (-18.44%)
AWKN.CN : 0.0950 (unch)
Awakn Announces Positive Outcome of Pre-IND Meeting with FDA for AWKN-002 in Alcohol Use Disorder Newsfile - Mon Jan 20, 2025

Toronto, Ontario--(Newsfile Corp. - January 20, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing...

AWKNF : 0.0650 (-18.44%)
AWKN.CN : 0.0950 (unch)
Awakn Life Sciences Announces Credit Facility Newsfile - Wed Dec 18, 2024

Toronto, Ontario--(Newsfile Corp. - December 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing therapeutics...

AWKNF : 0.0650 (-18.44%)
AWKN.CN : 0.0950 (unch)
Awakn Life Sciences Enters into Binding Letter of Intent for Acquisition of Awakn by Graft Polymer (UK) Plc Newsfile - Mon Dec 16, 2024

Toronto, Ontario--(Newsfile Corp. - December 16, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing therapeutics...

AWKNF : 0.0650 (-18.44%)
AWKN.CN : 0.0950 (unch)
Awakn Announces Promising Results from Aminoindane New Chemical Entity Pre-Clinical Program Newsfile - Tue Dec 10, 2024

Toronto, Ontario--(Newsfile Corp. - December 10, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing therapeutics...

AWKNF : 0.0650 (-18.44%)
AWKN.CN : 0.0950 (unch)
Awakn Announces Opening of Four Additional AWKN-001 Phase 3 Trial Sites Newsfile - Tue Oct 22, 2024

Toronto, Ontario--(Newsfile Corp. - October 22, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing therapeutics...

AWKNF : 0.0650 (-18.44%)
AWKN.CN : 0.0950 (unch)

Barchart Exclusives

Most Retail Investors Think They’re Investing: They’re Actually Trading The Market Barchart - Sat Feb 21, 10:10AM CST
Most retail investors think they’re investing in businesses, but they’re actually reacting to market noise instead of analyzing incentives, capital allocation, and structural change. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot